MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 162 filers reported holding MOMENTA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $11,343,000 | +23.8% | 216,130 | -21.5% | 0.01% | +14.3% |
Q2 2020 | $9,159,000 | +61.2% | 275,285 | +31.8% | 0.01% | +40.0% |
Q1 2020 | $5,680,000 | +83.1% | 208,833 | +32.8% | 0.01% | +150.0% |
Q4 2019 | $3,102,000 | +64.1% | 157,208 | +7.8% | 0.00% | 0.0% |
Q3 2019 | $1,890,000 | +36.5% | 145,800 | +31.1% | 0.00% | +100.0% |
Q2 2019 | $1,385,000 | -29.0% | 111,220 | -17.2% | 0.00% | -50.0% |
Q1 2019 | $1,952,000 | +96.8% | 134,346 | +49.5% | 0.00% | +100.0% |
Q4 2018 | $992,000 | -55.5% | 89,882 | +6.0% | 0.00% | -50.0% |
Q3 2018 | $2,229,000 | +29.2% | 84,759 | +0.5% | 0.00% | 0.0% |
Q2 2018 | $1,725,000 | +20.5% | 84,336 | +7.0% | 0.00% | +100.0% |
Q1 2018 | $1,431,000 | +50.5% | 78,837 | +15.6% | 0.00% | 0.0% |
Q4 2017 | $951,000 | -28.2% | 68,184 | -4.7% | 0.00% | 0.0% |
Q3 2017 | $1,324,000 | +3.4% | 71,575 | -5.5% | 0.00% | -50.0% |
Q2 2017 | $1,280,000 | +47.5% | 75,766 | +16.5% | 0.00% | +100.0% |
Q1 2017 | $868,000 | -12.9% | 65,009 | -1.9% | 0.00% | 0.0% |
Q4 2016 | $997,000 | +53.1% | 66,236 | +18.8% | 0.00% | 0.0% |
Q3 2016 | $651,000 | +25.0% | 55,731 | +15.6% | 0.00% | 0.0% |
Q2 2016 | $521,000 | +76.0% | 48,204 | +50.3% | 0.00% | – |
Q1 2016 | $296,000 | -44.5% | 32,074 | -10.8% | 0.00% | -100.0% |
Q4 2015 | $533,000 | -5.3% | 35,943 | +4.8% | 0.00% | 0.0% |
Q3 2015 | $563,000 | +6.8% | 34,290 | +48.3% | 0.00% | 0.0% |
Q2 2015 | $527,000 | +59.7% | 23,118 | +6.4% | 0.00% | 0.0% |
Q1 2015 | $330,000 | +27.9% | 21,734 | +1.3% | 0.00% | 0.0% |
Q4 2014 | $258,000 | +21.7% | 21,457 | +14.5% | 0.00% | – |
Q3 2014 | $212,000 | -15.2% | 18,738 | -12.5% | 0.00% | -100.0% |
Q1 2014 | $250,000 | -35.4% | 21,421 | -2.1% | 0.00% | 0.0% |
Q4 2013 | $387,000 | +41.8% | 21,890 | +15.5% | 0.00% | 0.0% |
Q3 2013 | $273,000 | -1.1% | 18,950 | +3.4% | 0.00% | 0.0% |
Q2 2013 | $276,000 | – | 18,324 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MONROE HALL ASSET MANAGEMENT LLC | 200,000 | $3,282,000 | 1.60% |
SECTOR GAMMA AS | 350,920 | $5,759,000 | 1.56% |
Opaleye Management Inc. | 160,000 | $2,626,000 | 1.29% |
Visium Asset Management, LP | 5,398,088 | $88,583,000 | 1.21% |
Palo Alto Investors LP | 1,455,176 | $23,879,000 | 1.15% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 4,597,915 | $75,452,000 | 0.84% |
Sivik Global Healthcare LLC | 90,000 | $1,477,000 | 0.72% |
Campbell & CO Investment Adviser LLC | 45,887 | $753,000 | 0.50% |
Apex Capital Management | 1,096,757 | $17,998,000 | 0.41% |
AlphaMark Advisors, LLC | 42,651 | $700,000 | 0.39% |